Bayer's Glucometer Dex
This article was originally published in The Gray Sheet
Executive Summary
U.S. launch of the home blood glucose monitoring system is expected in the first quarter of 1999, according to the company. "The Gray Sheet" (April 27, p. 10) had reported that the product would be introduced in the third quarter of 1998. Bayer will continue marketing its Glucometer Encore and Glucometer Elite systems following the launch of the Dex. The firm does not plan to release a Dex product for point-of-care testing
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.